abstract |
PROBLEM TO BE SOLVED: To provide a compound, a pharmaceutical composition, and a method for treating a disease or condition in which plasma kallikrein activity is involved, such as diabetic retinopathy, hereditary angioedema, diabetic macular edema, and retinal vein occlusion. .. For example, a compound of the following formula is shown. [Selection diagram] None |